Sirnaomics Ltd. (HKG:2257)
Hong Kong · Delayed Price · Currency is HKD 7.17
+0.27 (3.91%)
At close: Feb 13, 2026
Sirnaomics Employees
Sirnaomics had 52 employees as of June 30, 2025. The number of employees decreased by 17 or -24.64% since the number was reported on December 31, 2024.
Employees
52
Change
-17
Growth
-24.64%
Revenue / Employee
143.26K HKD
Profits / Employee
-2.12M HKD
Market Cap
762.88M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Jun 30, 2025 | 52 | -17 | -24.64% | 52 | 0 |
| Dec 31, 2024 | 69 | -76 | -52.41% | 69 | 0 |
| Dec 31, 2023 | 145 | -80 | -35.56% | 145 | 0 |
| Dec 31, 2022 | 225 | 50 | 28.57% | 222 | 3 |
| Dec 31, 2021 | 175 | 18 | 11.46% | 175 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Uni-Bio Science Group | 504 |
| JW (Cayman) Therapeutics Co. | 292 |
| 3D Medicines | 183 |
| Transcenta Holding | 171 |
| Kintor Pharmaceutical | 136 |
| Beijing Biostar Pharmaceuticals | 131 |
| Sunho Biologics | 128 |
| Wuhan YZY Biopharma | 106 |
Sirnaomics News
- 5 months ago - Basal Cell Neoplasms Clinical Trial Pipeline Accelerates as 22+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight - Benzinga